A New Treatment for Localized Prostate Cancer Lets Men Keep the Sexual Passion in Their Relationships
WOMEN Magazine - Fall 2018
By Dr. Cary N. Robertson MD. Medically reviewed by Dr. C.H. Weaver, MD. — SEPTEMBER 25, 2018
In the years since the first North American clinical trial to evaluate its safety and effectiveness, High Intensity Focused Ultrasound (HIFU) has emerged as a viable procedure for patients to consider after receiving a diagnosis of localized prostate cancer.
That study, begun in 2007 and known as the Enlight Trial, examined the efficacy of HIFU in participating patients diagnosed with low grade, low volume prostate cancer. In 2015, the FDA cleared transrectal ultrasound guided HIFU as a surgical tool for prostate tissue ablation. Around the world, more than 45,000 patients have undergone the prostate HIFU procedure.